Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 13 studies | 57% ± 26% | |
| oligodendrocyte precursor cell | 13 studies | 42% ± 18% | |
| astrocyte | 12 studies | 26% ± 16% | |
| GABAergic neuron | 11 studies | 54% ± 25% | |
| oligodendrocyte | 11 studies | 30% ± 12% | |
| retinal ganglion cell | 7 studies | 41% ± 17% | |
| interneuron | 6 studies | 66% ± 22% | |
| neuron | 5 studies | 41% ± 8% | |
| endothelial cell | 4 studies | 37% ± 18% | |
| granule cell | 4 studies | 71% ± 9% | |
| endothelial cell of lymphatic vessel | 4 studies | 22% ± 3% | |
| GABAergic interneuron | 3 studies | 55% ± 12% | |
| GABAergic amacrine cell | 3 studies | 41% ± 12% | |
| ON-bipolar cell | 3 studies | 22% ± 1% | |
| amacrine cell | 3 studies | 41% ± 9% | |
| glycinergic amacrine cell | 3 studies | 35% ± 8% | |
| rod bipolar cell | 3 studies | 28% ± 13% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 16 studies | 42% ± 22% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 7110.51 | 2641 / 2642 | 100% | 36.58 | 702 / 705 |
| prostate | 99% | 2035.24 | 242 / 245 | 87% | 6.23 | 439 / 502 |
| adrenal gland | 100% | 2310.25 | 257 / 258 | 87% | 9.76 | 199 / 230 |
| kidney | 91% | 890.36 | 81 / 89 | 70% | 4.33 | 635 / 901 |
| breast | 77% | 591.43 | 354 / 459 | 55% | 2.46 | 616 / 1118 |
| uterus | 98% | 1355.47 | 167 / 170 | 34% | 2.00 | 155 / 459 |
| thymus | 99% | 1273.15 | 647 / 653 | 29% | 1.14 | 178 / 605 |
| ovary | 92% | 1049.42 | 166 / 180 | 11% | 0.44 | 47 / 430 |
| intestine | 65% | 427.32 | 625 / 966 | 29% | 1.12 | 154 / 527 |
| bladder | 62% | 653.38 | 13 / 21 | 24% | 1.08 | 123 / 504 |
| pancreas | 7% | 35.11 | 24 / 328 | 74% | 4.35 | 131 / 178 |
| lung | 57% | 307.97 | 327 / 578 | 23% | 0.98 | 260 / 1155 |
| adipose | 76% | 693.44 | 917 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 64% | 338.27 | 155 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 59% | 436.00 | 793 / 1335 | 0% | 0 | 0 / 0 |
| skin | 21% | 114.97 | 384 / 1809 | 34% | 1.68 | 161 / 472 |
| stomach | 17% | 87.90 | 62 / 359 | 34% | 1.32 | 97 / 286 |
| esophagus | 20% | 104.91 | 282 / 1445 | 25% | 1.15 | 45 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 1.57 | 15 / 45 |
| heart | 23% | 105.21 | 197 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 19% | 415.50 | 180 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 0.51 | 5 / 29 |
| muscle | 7% | 34.80 | 60 / 803 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 6% | 0.20 | 24 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.06 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007162 | Biological process | negative regulation of cell adhesion |
| GO_0007155 | Biological process | cell adhesion |
| GO_0006508 | Biological process | proteolysis |
| GO_0007417 | Biological process | central nervous system development |
| GO_0098839 | Cellular component | postsynaptic density membrane |
| GO_0030424 | Cellular component | axon |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0016020 | Cellular component | membrane |
| GO_0004222 | Molecular function | metalloendopeptidase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0005178 | Molecular function | integrin binding |
| Gene name | ADAM22 |
| Protein name | Uncharacterized protein ADAM22 ADAM metallopeptidase domain 22 Disintegrin and metalloproteinase domain-containing protein 22 (ADAM 22) (Metalloproteinase-disintegrin ADAM22-3) (Metalloproteinase-like, disintegrin-like, and cysteine-rich protein 2) ADAM22 protein Metalloproteinase-disintegrin ADAM metallopeptidase domain 22 (cDNA FLJ77109, highly similar to Homo sapiens MDC2 mRNA) |
| Synonyms | MDC2 |
| Description | FUNCTION: Probable ligand for integrin in the brain. This is a non catalytic metalloprotease-like protein . Involved in regulation of cell adhesion and spreading and in inhibition of cell proliferation. Neuronal receptor for LGI1. . |
| Accessions | ENST00000426930.5 F8WAD8 H7C0Q9 A0A804HHS1 Q9UKK0 Q08AL8 ENST00000682337.1 Q8IYE7 ENST00000684002.1 [Q9P0K1-4] ENST00000265727.11 [Q9P0K1-1] ENST00000398201.8 [Q9P0K1-3] H7C3I4 ENST00000398209.7 [Q9P0K1-2] Q9P0K1 Q75MS7 ENST00000398203.8 ENST00000413139.2 Q6P667 Q86UM2 E9PF78 ENST00000683525.1 ENST00000412441.5 ENST00000398204.8 [Q9P0K1-5] A0A804HIW1 |